Eli Lilly

Eli Lilly Expands Cancer Treatment Pipeline with $2.5 Billion Scorpion Therapeutics Deal

Eli Lilly and Company, a global leader in pharmaceutical innovation, announced its intent to acquire Scorpion Therapeutics’ experimental cancer therapy,…

56 years ago

Alphabet Welcomes New CFO Anat Ashkenazi from Eli Lilly

In a strategic move, Alphabet Inc. has appointed Anat Ashkenazi, a seasoned veteran from Eli Lilly and Company, as the…

56 years ago